Loading...
Loading...
Trademark Dashboard – UK Trademark Search & ClearanceApplication 2026351807 · 00
| Application Number | 2026351807 |
| Registration Number | 1900633 |
| Status | 00 |
| Mark Type | madrid |
| Owner | Glaxo Group Limited |
| Filed | 2026-02-05 |
| Registered | 2025-12-02 |
2026351807 has a current status of 00.
The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.
Pharmaceutical and medicinal preparations and substances; vaccines.
| Name (romanised) | Glaxo Group Limited |
This device mark (application number 2026351807) is a 00 trademark on the Japan Patent Office register, filed by Glaxo Group Limited on 5 February 2026, with registration granted on 2 December 2025.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations), specifically covering: Pharmaceutical and medicinal preparations and substances; vaccines.
No — the Japan Patent Office records the status of Japanese trademark 2026351807 as 00.
Japanese trademark 2026351807 is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical and medicinal preparations and substances; vaccines.
Japanese trademark 2026351807 was filed at the Japan Patent Office on 5 February 2026 and registered on 2 December 2025.
Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-18.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.